Rat Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine (contains cat# RA800TC-1 with 50ml ExoQuick-TC, RA805A-1 and RA812A-1 components)

Product Description

• Reliable, reproducible exoRNA isolation from most biofluids
• Sensitive detection via exoRNA amplification
• Everything you need including 384-well plate of rat miRNAs for qPCR profiling

Get your exosomal RNA profiling studies off the ground fast with everything you need for profiling exosomal RNAs from most biofluids, SBI’s Rat Complete SeraMir Exosome RNA Amplification & Profiling Kit is a great way to get started with exoRNA profiling. The kit includes the fast and efficient ExoQuick-TC Exosome Isolation Reagent, phenol-free SeraMir exosome RNA purification reagents and columns, reagents for cDNA synthesis and amplification, and one 384-well plate with rat miRNAs and control wells for quantitation of isolated exoRNAs. (NOTE: for exoRNA isolation from serum, plasma, or ascites fluid, try the Rat Complete SeraMir Kit).

How it Works

Quickly and easily profile exoRNAs

• Isolate exosomes from rat biofluids with the included ExoQuick reagent
• Purify exoRNAs with SeraMir columns
• Measure expression levels of 380 rat miRNAs in a 384-well qPCR assay

Find more detailed information about the product line and how SeraMir Kits work on page Exosome microRNA Amplification and Profiling.

Free Software

Find out which miRNAs are included in the SeraMir Rat 384 qPCR miRNA Primer List & Free Software.

Choose the SeraMir Kit that’s right for you

Supporting Data

Better qPCR profiling with SeraMir

Figure 1. Serum RNA prepared by the SeraMir Kit delivers more reliable, reproducible qPCR profiles than when the RNA is isolated using conventional Trizol methods. Profiling of 380 Human microRNAs across the SeraMir 384 Profiler. The phenol-free exosome lysis step coupled to the small RNA binding columns isolates exoRNAs with much higher purity than Trizol/Phenol based methods. The SeraMir exoRNAs are compatible with downstream polyadenylation and reverse trancription reactions for amplification and accurate qPCR profiling.

Figure 2. Serum exoRNAs prepared using SeraMir deliver excellent performance in microarray studies. Samples from a pooled normal serum preparation and from a male caucasian (age 73) with adenocarcinoma of the colon were used in this study. Exosomes were precipitated from 250 µL of serum using the SeraMir Exosome RNA Amplification Kit. The T7-amplified “sense” exoRNAs were then used for direct labeling analyses on LC Sciences miRBase ver.16 array chips (performed in triplicate). The exoRNAs were hybridized across 1,214 different microRNAs on the probe set. Of the 1,214 microRNAs analyzed, 79 microRNAs showed a signal intensity >32. Within this set of 79, there was a clear colon versus normal “signature set” of 40 microRNAs that could discriminate normal from colon cancer serum samples with a p-value < 0.01. The identities of the microRNAs found in this study have been masked while further investigation continues.